Our Company
Our Company
Our Strategy
Governance
Governance
Board of Directors
Executive Committee
Specialist Committees
Social Impact
Social Impact
Access to Healthcare
Innovation for Vulnerable Communities
Environmental Sustainability and Resilience
Diversity, Equity, and Inclusion In and Beyond the Workplace
Responsible Business Values
Our Legacy
Our Science
Our Science
Our Pipeline
R&D Focus Areas
R&D Focus Areas
Immunology R&D
Neurology R&D
Oncology R&D
Rare Blood Disorders R&D
Rare Diseases R&D
Vaccines R&D
Technology Platforms
Clinical trials & results
Clinical trials & results
Clinical Study Results
Investigator Sponsored Studies
Diversity in Clinical Trials
Scientific Collaboration
Scientific Collaboration
Scientific Collaboration in North America
Scientific Collaboration in Europe
Scientific Collaboration in China
Your Health
Your Health
Vaccines
Vaccines
Influenza
Meningococcal meningitis
Pertussis
Respiratory Syncytial Virus
Production
Why vaccines matter
Medicines
Medicines
Immunology
Neurology
Oncology
Rare Blood Disorders
Rare Diseases
Cardiovascular Diseases
Diabetes
Consumer Healthcare
Patient Support
Relations with Healthcare Professionals
Partnering
Partnering
Partnering Focus Areas
Partnering Focus Areas
China
Digital
General Medicines
Immunology
Neuroscience
Oncology
Out-Licensing
Rare Disease
Technology Platforms
Vaccines
Meet the Partnering Team
Media
Media
Press Releases
Media Contacts
Investor Relations
Investor Relations
Financial Result and Investor Events
Financial Result and Investor Events
Quarterly Results
Investor Presentations
Annual General Meetings
Broker conferences
Environment, Social, Governance
Environment, Social, Governance
Our Double Materiality Assessment
Our Latest ESG news
ESG Newsletters
Individual Shareholders
Individual Shareholders
Being a Shareholder
How to buy Sanofi Shares
Shares and ADRs
Shares and ADRs
Sanofi stock chart
Dividends
ADRs
Shareholding structure
Vara consensus
Shares & voting rights
Share repurchases
Financial Reports and Publications
Financial Reports and Publications
Financial Reports and Regulated Information
Shareholder publications
Financial Reporting Center and Key Data
Contacts
Careers
Careers
Global Terms and Conditions
Paris 2024 Partnership
Global
Home
Second quarter 2023 results
Second quarter 2023 results
Highlights
(14:30 - 16:00 CEST)